Recent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases

In the past two decades, genome editing has proven its value as a powerful tool for modeling or even treating numerous diseases. After the development of protein-guided systems such as zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), which for the first time...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreurs, Juliët, Sacchetto, Claudia, Colpaert, Robin M. W., Vitiello, Libero, Rampazzo, Alessandra, Calore, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537312/
https://www.ncbi.nlm.nih.gov/pubmed/34681646
http://dx.doi.org/10.3390/ijms222010985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537312/
https://www.ncbi.nlm.nih.gov/pubmed/34681646
http://dx.doi.org/10.3390/ijms222010985

Ejemplares similares